American drugmaker Moderna said on Thursday, April 12, that it had paused its plans to build an mRNA vaccine manufacturing plant in Kenya as demand for vaccines in Africa falls.
"The demand in Africa for COVID-19 vaccines has declined since the pandemic and is insufficient to support the viability of the factory planned in Kenya," the company said in a statement. The company announced in March 2022 that it was planning to invest $500 million in the facility, which would be able to produce up to 500 million doses of mRNA vaccines each year.
It added that it is actively working on the development of vaccines, including those for diseases that predominantly affect the African continent, such as HIV and malaria and that these investigational vaccines are at an early development stage.
Moderna Vaccine Manufacturing Plant Kenya Africa COVID-19 Demand
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: allafrica - 🏆 1. / 99 Read more »
Source: htxtafrica - 🏆 42. / 51 Read more »
Source: allafrica - 🏆 1. / 99 Read more »
Kenya: Producer Element Takes His Sound to Kenya24-Year-
Source: allafrica - 🏆 1. / 99 Read more »
Kenya: Rwanda, Kenya Commit to Enhance Transport Along Northern CorridorGovernment officials from Rwanda and Kenya convened to bolster cooperation between the two nations and enhance transport services along the northern corridor, aiming to strengthen trade and streamline the movement of goods and people through improved connectivity.
Source: allafrica - 🏆 1. / 99 Read more »
Source: allafrica - 🏆 1. / 99 Read more »